Semaglutide NAION Risk: EMA Review Initiated Am...

By João L. Carapinha

January 21, 2025

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the potent...
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
National Health Survey 2024 Progress: Key Insights and Future Impacts
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Transforming Africa through Healthcare Biotechnology Innovation
Cholera Vaccination Campaign Amid Ongoing Outbreak
Pharmaceutical Data Collaboration Between Canada’s Drug Agency and CIHI
Blueprint for Transforming Healthcare Access in Africa
Virus-Free Regenerative Medicine: Abu Dhabi’s Stem Cells Center
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions